These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19367002)

  • 21. Microcirculation and oxidative stress.
    Crimi E; Ignarro LJ; Napoli C
    Free Radic Res; 2007 Dec; 41(12):1364-75. PubMed ID: 18075839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
    Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
    Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and nitric oxide deficiency in inflammation of chronic renal failure. Possible preventive role of L-arginine and multiple antioxidants.
    Korish AA
    Saudi Med J; 2009 Sep; 30(9):1150-7. PubMed ID: 19750259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts.
    Djamali A
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F445-55. PubMed ID: 17459952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astaxanthin, oxidative stress, inflammation and cardiovascular disease.
    Fassett RG; Coombes JS
    Future Cardiol; 2009 Jul; 5(4):333-42. PubMed ID: 19656058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress in hypertension: association with antihypertensive treatment.
    Khanna HD; Sinha MK; Khanna S; Tandon R
    Indian J Physiol Pharmacol; 2008; 52(3):283-7. PubMed ID: 19552060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.
    Lim TK; Choy AJ; Khan F; Belch JJ; Struthers AD; Lang CC
    Cardiovasc Ther; 2009; 27(1):49-58. PubMed ID: 19207480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome?
    Madill J; Aghdassi E; Arendt B; Hartman-Craven B; Gutierrez C; Chow CW; Allard J;
    Transplant Rev (Orlando); 2009 Apr; 23(2):103-10. PubMed ID: 19298941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
    Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Malý J; Kramer HJ; Dvorák P; Cervenka L
    Vascul Pharmacol; 2009; 51(2-3):175-81. PubMed ID: 19539780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension.
    Houston MC
    Prog Cardiovasc Dis; 2005; 47(6):396-449. PubMed ID: 16115519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hyperglycemia and oxidative stress: direct cause and effect?
    Choi SW; Benzie IF; Ma SW; Strain JJ; Hannigan BM
    Free Radic Biol Med; 2008 Apr; 44(7):1217-31. PubMed ID: 18226604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidant stress and inflammation in the snoring child: confluent pathways to upper airway pathogenesis and end-organ morbidity.
    Gozal D; Kheirandish L
    Sleep Med Rev; 2006 Apr; 10(2):83-96. PubMed ID: 16495092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
    Nambiar S; Viswanathan S; Zachariah B; Hanumanthappa N; Magadi SG
    Angiology; 2009; 60(2):221-34. PubMed ID: 18796443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
    Subramaniam V; Lip GY
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):703-13. PubMed ID: 19505285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism.
    Weber KT
    Herz; 2003 Dec; 28(8):692-701. PubMed ID: 14689103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathophysiology of target organ damage in hypertension.
    Karpha M; Lip GV
    Minerva Cardioangiol; 2006 Aug; 54(4):417-29. PubMed ID: 17016413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvascular oxidative stress, immune reaction and apoptosis in hypertensives.
    Suzuki H; Suematsu M; Schmid-Schönbein GW
    Clin Hemorheol Microcirc; 1999; 21(3-4):161-8. PubMed ID: 10711738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension.
    Vaziri ND
    Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):93-9. PubMed ID: 15090865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin as a clinical target in the treatment of systemic hypertension.
    Prasad VS; Palaniswamy C; Frishman WH
    Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.